CCL2 and rheumatoid arthritis: In the CIA mouse model, the combination of curcumin and n-3 FA delayed disease progression, reduced disease severity, and significantly inhibited the factors related to RA occurrence, such as TNF, IFN-γ, and MCP-1 (161).